
Healthcare Product Manufacturers, Health Service Providers
Source: Medical Device Innovation Network,Medical Device Repair Alliance
Reprinted: IVD Tool Man
Recently, GE Healthcare announced that Chuhui Chen has been appointed asAdvanced Visualization SolutionSolution(AVS) Vice President and General Manager of the China Region, effective from October 8.GE Healthcare stated that Chen Chuhui will be fully responsible for driving the business growth of the AVS division in China and will work closely with the ultrasound, IGS, and surgical teams in formulating GTM commercial strategies. These strategies primarily aim to strengthen product management and promote local commercial operations. He will represent China in the global AVS division and play a key role in enhancing collaboration to drive continuous innovation and business growth in China.
Before joining GE Healthcare, Chen Chuhui served as the General Manager of the Cardiovascular and Specialty Solutions Division at Johnson & Johnson Medical Technology China, while also overseeing external affairs and market access. He officially left Johnson & Johnson on September 16 this year, marking the beginning of a new professional chapter.
Chen Chuhui worked at Johnson & Johnson for 14 years, earning widespread respect and recognition through his exceptional leadership, profound expertise, and dedicated mentorship of talent.
It is worth mentioning that Chen Chuhui has a deep connection with GE Healthcare.As early as 1993, he joined GE Healthcare as a customer service engineer. Since then, he has worked in various positions including the head of MR SVC in North China, North China Service Manager, Sales Operations and Marketing Manager, MR Sales Manager, and Service Operations Manager, until he left the company in 2004.
GE Healthcare warmly welcomes the addition of Chuchui Chan, highlighting his over 30 years of extensive experience in the healthcare field, as well as his exceptional leadership and business acumen, which will bring new external perspectives and strategic insights to the company. GE Healthcare is confident that Chuchui Chan will lead the AVS division to even greater achievements in the China region.
GE Healthcare Experienced Significant Personnel Changes in 2024: The Following Are Some of the Main Personnel Movements:
July 8, 2024, GE HealthcareImaging CEO Jan Makela DepartsJan Makela has worked at GE Healthcare for over 17 years. As the President of the Medical Imaging business, he led several partnerships and acquisitions, making significant contributions to GE Healthcare's imaging business. However, he left on July 8, 2024, to join another private company that is not a competitor.
July 1, 2024Roland Rott takes overPresident and Chief Executive Officer of Medical Imaging BusinessRoland Rott has many years of working experience at GE Healthcare and has held several leadership positions in the ultrasound department. He succeeds Jan Makela as the new president of the medical imaging business and is committed to driving continuous innovation and development within GE Healthcare's medical imaging field.
July 1, 2024Philip Rackliffe's position has been adjusted to President and CEO of the Ultrasound and Image-Guided Therapy (IGT) business.Philip Rackliffe was formerly the President and CEO of GE Healthcare's Image Guided Therapy (IGT). Following the merger of the IGT business with the ultrasound business, he became the President and CEO of the newly merged division, responsible for driving the synergistic development of both businesses.
May 2024,Adam Holton Appointed as Chief Human Resources Officer of GE Healthcare(CPO), responsible for leading the company's human resources department. His joining will help GE Healthcare achieve better results in talent management, organizational development, and other aspects.
The third quarter of 2024,IGT Merges with GE Healthcare Ultrasound Business.GE Healthcare Merges $1.6 Billion Image-Guided Therapy (IGT) Business with Ultrasound Unit to Form Global Business with Over $5 Billion in Annual Revenue
According to GE Healthcare's financial report for the first half of the 2024 fiscal year, GE Healthcare's revenue was $9.849 billion, basically flat compared to the same period last year. However, revenue in China was only $1.180 billion, a year-on-year decrease of 15%.
Ultrasound business is GE Healthcare's second largest business, accounting for 17%, but in the second quarter of 2024, GE Healthcare's ultrasound business saw an organic growth of -1%. GE Healthcare attributed the cause to the impact of sluggish orders in the Chinese market.
Currently, China is carrying out large-scale equipment upgrades and consumer goods trade-in programs, rapidly unleashing the demand for equipment renewal in medical institutions. In this context, could the key personnel appointments at GE Healthcare be aimed at driving revenue growth in the China region by leveraging this opportunity? Let's wait and see.
Industry Group


Statement:This article only represents the author's viewpoint and does not represent the platform's position.If the reprint involves copyright and other issues, please contact us as soon as possible. We will correct or delete it in the first instance. Thank you!